Search for a Veterinary Medicine

For centrally authorised product information click here

For Summary of Product Characteristics (SPCs) of new products that have been granted a marketing authorisation since February 2022 in accordance with Regulation 2019/6, the format and content of the SPC has changed compared to those issued beforehand. In particular sections 7, 8, 9 and 10 (specifying information on the marketing authorisation holder, marketing authorisation number, date of first authorisation and date of revision of the text) are not included in the SPC document itself (these fields appear blank), as this information is provided on the national-specific product information landing page of the website (from which you click through to the SPC document itself).

The HPRA advises healthcare professionals not to retain printed versions of SPC documents, as these documents are subject to change and updating, including changes to safety and dose related information. We recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about the SPCs on our website e-mail vetinfo@hpra.ie


  • Veterinary Medicines
 
 

Download

Latest list of Authorised or Transfer Pending Products
PDF VersionXML Version

Showing 1-20 of 70 matching medicines

Product listings were last updated on 01/12/2022
Trade Name Licence Number & Holder Documents
Cladaxxa 200 mg/50 mg chewable tablets for cats and dogs
Chewable tablet

Compare
VPA10774/071/002
Authorised: 18/06/2021
Krka, d.d., Novo mesto
SPC IPAR
Cladaxxa 40 mg/10 mg chewable tablets for cats and dogs
Chewable tablet

Compare
VPA10774/071/001
Authorised: 18/06/2021
Krka, d.d., Novo mesto
SPC IPAR
Cladaxxa 400 mg/100 mg chewable tablets for dogs
Chewable tablet

Compare
VPA10774/071/003
Authorised: 18/06/2021
Krka, d.d., Novo mesto
SPC IPAR
Clavaseptin 250 mg palatable tablets for dogs
Tablet

Compare
VPA10983/048/002
Authorised: 21/10/2005
Vetoquinol Ireland Limited
SPC Variations
Clavaseptin 50 mg palatable tablets for dogs and cats
Tablet

Compare
VPA10983/048/001
Authorised: 21/10/2005
Vetoquinol Ireland Limited
SPC Variations
Clavaseptin 500 mg palatable tablets for dogs
Tablet

Compare
VPA10983/048/003
Authorised: 21/10/2005
Vetoquinol Ireland Limited
SPC Variations
Clavaseptin 62.5 mg Palatable tablets for dogs and cats
Tablet

Compare
VPA10983/048/004
Authorised: 26/04/2013
Vetoquinol Ireland Limited
SPC Variations
Clavaseptin 750 mg palatable tablets for dogs
Tablet

Compare
VPA10983/048/005
Authorised: 08/04/2022
Vetoquinol Ireland Limited
SPC Variations
Clavubactin 250/62.5 mg tablets for dogs
Tablet

Compare
VPA10475/014/002
Authorised: 08/11/2013
Le Vet Beheer B.V.
SPC
Clavubactin 50/12.5 mg tablets for cats and dogs
Tablet

Compare
VPA10475/014/001
Authorised: 08/11/2013
Le Vet Beheer B.V.
SPC
Clavubactin 500/125 mg tablets for dogs
Tablet

Compare
VPA10475/014/003
Authorised: 08/11/2013
Le Vet Beheer B.V.
SPC
Clavucill 200mg/50mg, tablets for dogs
Tablet

Compare
VPA10817/002/002
Authorised: 22/05/2015
V.M.D. n.v/s.a.
SPC IPAR Variations
Clavucill 40mg/10mg, tablets for dogs and cats
Tablet

Compare
VPA10817/002/001
Authorised: 22/05/2015
V.M.D. n.v/s.a.
SPC IPAR Variations
Clavudale 200 mg/50 mg tablets for dogs
Tablet

Compare
VPA22622/005/002
Authorised: 15/04/2011
Dechra Regulatory B.V.
SPC IPAR
Clavudale 40 mg/10 mg tablets for cats and dogs
Tablet

Compare
VPA22622/005/001
Authorised: 28/10/2011
Dechra Regulatory B.V.
SPC IPAR
Clavudale 400 mg/100 mg tablets for dogs
Tablet

Compare
VPA22622/005/003
Authorised: 15/04/2011
Dechra Regulatory B.V.
SPC IPAR
CLIK 5% Pour-on Suspension for Sheep
Pour-on suspension

Compare
VPA22020/021/001
Authorised: 17/06/2016
Elanco GmbH
SPC Variations
CLiK Extra 65 mg/ml Pour-On Suspension for Sheep
Pour-on suspension

Compare
VPA22020/022/001
Authorised: 25/11/2016
Elanco GmbH
SPC IPAR Variations
CLiKZiN 12.5 mg/ml Pour-On Suspension for Sheep
Pour-on suspension

Compare
VPA22020/023/001
Authorised: 17/06/2016
Elanco GmbH
SPC IPAR Variations
Clinacin 150 mg Tablets for Dogs
Tablet

Compare
VPA10987/144/003
Authorised: 26/11/1999
Chanelle Pharmaceuticals Manufacturing Limited
SPC Variations